These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8619601)

  • 1. Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.
    Tanaka M; Matsumoto T; Kobayashi I; Uchino U; Kumazawa J
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2367-70. PubMed ID: 8619601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
    Tanaka M; Kumazawa J; Matsumoto T; Kobayashi I
    Genitourin Med; 1994 Apr; 70(2):90-3. PubMed ID: 8206482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
    Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
    J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
    Carlyn CJ; Doyle LJ; Knapp CC; Ludwig MD; Washington JA
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1606-8. PubMed ID: 7492114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
    Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
    Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.
    Zenilman JM; Neumann T; Patton M; Reichart C
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2244-6. PubMed ID: 8257153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
    Akasaka S; Muratani T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
    J Infect Chemother; 2001 Mar; 7(1):49-50. PubMed ID: 11406757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones.
    Fox KK; Knapp JS; Holmes KK; Hook EW; Judson FN; Thompson SE; Washington JA; Whittington WL
    J Infect Dis; 1997 Jun; 175(6):1396-403. PubMed ID: 9180179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
    Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
    Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
    Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
    Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics.
    Tanaka M; Nakayama H; Haraoka M; Saika T; Kobayashi I; Naito S
    Antimicrob Agents Chemother; 2000 Jan; 44(1):192-5. PubMed ID: 10602748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.
    Knapp JS; Neal SW; Parekh MC; Rice RJ
    Antimicrob Agents Chemother; 1995 Apr; 39(4):987-9. PubMed ID: 7786010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of quinolone-resistant Neisseria gonorrhoeae.
    Kam KM; Wong PW; Cheung MM; Ho NK
    J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.